Non-neuronal dopamine in the gastrointestinal system

Area of Science:

• Gastroenterology
• Neuroscience
• Cell Biology

Background:

• Dopamine (DA) demonstrates protective effects within the gastrointestinal (GI) tract.
• The precise sites of DA production in the GI tract remain incompletely understood.

Purpose of the Study:

• To investigate the cellular sources and localization of dopamine production within the rat and human GI tract.
• To explore the potential role of locally produced dopamine in mucosal protection.

Main Methods:

• Immunocytochemistry (ICC)
• In situ hybridization histochemistry
• Reverse transcription-polymerase chain reaction (RT-PCR)
• High-performance liquid chromatography (HPLC)
• Western blotting
• Immunoelectron microscopy
• Cell fractionation

Main Results:

• High concentrations of dopamine were detected in gastric juice, stomach mucosa, and pancreas, persisting after chemical sympathectomy.
• Tyrosine hydroxylase (TH) activity, crucial for DA synthesis, was found in stomach mucosa and pancreas and remained after sympathectomy.
• Parietal cells in the stomach and exocrine pancreas cells were identified as sites of dopamine production.
• Isolated rat stomach parietal cells exhibited dopamine and TH activity, along with dopamine transporters and D5 receptors.
• Dopamine, its synthetic enzymes, and transporters were also identified in human stomach parietal cells.

Conclusions:

• Dopamine is locally synthesized by parietal cells in the stomach and pancreatic cells.
• The presence of dopamine and its receptors suggests a localized mucosal protective system in the GI tract.
• This dopamine-mediated system may hold significant clinical relevance for gastrointestinal health.